Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse. 2018

Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
Division of Pharmacology and Pharmacotherapy, University of Helsinki, Viikinkaari 5E, P.O. Box 56, 00014, Helsinki, Finland.

Alpha-synuclein is the main component of Lewy bodies, a histopathological finding of Parkinson's disease. Prolyl oligopeptidase (PREP) is a serine protease that binds to α-synuclein and accelerates its aggregation in vitro. PREP enzyme inhibitors have been shown to block the α-synuclein aggregation process in vitro and in cellular models, and also to enhance the clearance of α-synuclein aggregates in transgenic mouse models. Moreover, PREP inhibitors have induced alterations in dopamine and metabolite levels, and dopamine transporter immunoreactivity in the nigrostriatal tissue. In this study, we characterized the role of PREP in the nigrostriatal dopaminergic and GABAergic systems of wild-type C57Bl/6 and PREP knockout mice, and the effects of PREP overexpression on these systems. Extracellular concentrations of dopamine and protein levels of phosphorylated dopamine transporter were increased and dopamine reuptake was decreased in the striatum of PREP knockout mice, suggesting increased internalization of dopamine transporter from the presynaptic membrane. Furthermore, PREP overexpression increased the level of dopamine transporters in the nigrostriatal tissue but decreased phosphorylated dopamine transporters in the striatum in wild-type mice. Our results suggest that PREP regulates the function of dopamine transporter, possibly by controlling the phosphorylation and transport of dopamine transporter into the striatum or synaptic membrane.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000085822 Prolyl Oligopeptidases A family of serine proteases with specificity for proline-specific cleavage of peptides that are not longer than 30 amino acids. In humans it is broadly distributed in all tissues with higher activity found in the brain. Post-Proline Cleaving Enzyme,Post-Proline Endopeptidase,Proline Endopeptidase,Proline Specific Endopeptidase,Prolyl Endopeptidase,Prolyl Endopeptidase (Thiol-dependent),Prolyl Endopeptidase I,Prolyl Oligopeptidase,Endopeptidase I, Prolyl,Endopeptidase, Post-Proline,Endopeptidase, Proline Specific,Oligopeptidases, Prolyl,Post Proline Cleaving Enzyme,Post Proline Endopeptidase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras

Related Publications

Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
February 2021, International journal of molecular sciences,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
October 2022, Nature communications,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
June 2019, Molecular reproduction and development,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
August 2009, The European journal of neuroscience,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
August 1999, The Journal of biological chemistry,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
July 1998, Cell,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
February 2002, Cellular and molecular life sciences : CMLS,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
June 2011, Journal of molecular histology,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
September 2012, Neurochemical research,
Ulrika H Julku, and Anne E Panhelainen, and Saija E Tiilikainen, and Reinis Svarcbahs, and Anne E Tammimäki, and T Petteri Piepponen, and Mari H Savolainen, and Timo T Myöhänen
June 2014, Basic & clinical pharmacology & toxicology,
Copied contents to your clipboard!